drugset / Trial / NCT01277341

Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis

NCT01277341

Phase 2 Completed 601 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupDouble-blindTreatment

Summary

This is an efficacy study of bepotastine besilate nasal spray in seasonal allergic rhinitis.

Timeline

Start
2010-12
Primary completion
2011-02
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Bepotastine Small molecule 2 % Intranasal
Subject Bepotastine Small molecule 3 % Intranasal
Subject Bepotastine Small molecule 4 % Intranasal